(This user asked anonymously)
International Cooperation Officer  |  Thailand

Should we consider different CETs in various situations e.g. rare diseases or end-stage diseases?

Asked: 17 Jan 2024  |   286
Should we consider different CETs in various situations e.g. rare diseases or end-stage diseases?
Health policy

Leave your reply:

Please sign in before leaving a reply.

Expert Profiles

Yot Teerawattananon

Senior Researcher
Health Intervention and Technology Assessment Program (HITAP)
Costing Modelling Health policy

Dr Abdur Razzaque Sarker

Health Economist
Health Economics and Financing Research, BIDS and Visiting Research Scholar, Health Economics Unit, University of Melbourne, Australia
Costing
Have a question?
Please sign in before asking an expert.